LDS/Medical Tests/PHOX2B gene mutation analysis

PHOX2B gene mutation analysis

Neuroblastoma paired type homeobox protein (PHOX2B) is located on short (p) arm of chromosome 4 at position 13. The protein encoded by this gene is a transcription factor belonging to a family of homeobox proteins found in the nucleus and is responsible for differentiation and development of noradrenergic neurons. Common mutations of the PHOX2B gene responsible for hereditary neuroblastoma involves alanine repeat expansion in exon 3. Hereditary neuroblastoma follows an autosomal dominant pattern of inheritance. Neuroblastic tumors present non–specifically in early childhood with fever, back ache, abdominal mass (adrenal involvement), diarrhea, constipation, flushed skin, chest pain, tachypnea, wheezing, hypertension weight loss, proptosis etc and may metastasize to various organs like skin and bone.

Several mutations, (typically polyalanine repeat expansions) in the PHOX2B gene have also been found to cause congenital central hypoventilation syndrome (CCHS). CCHS presents in two forms, a classic form which manifests immediately after birth, and a milder later-onset form. The condition is characterized by respiratory insufficiency although there may be other features of deregulation of the autonomic nervous system. Some patients of CCHS may additionally present with Hirschsprungs disease and may present with abdominal distension, failure to thrive, vomiting, constipation and diarrhea. Individuals with mutations of PHOX2B gene are at higher risk to develop tumors like neuroblastoma, ganglioneuroblastoma and ganglioneuroma. The risk being highest in infancy and decreases with age.

  • # Neuroblastoma
  • In diagnosis of Hereditary neuroblastoma
  • Prenatal assessment for neuroblast tumor risk factors in pregnancy
  • To screen for risk factors for neuroblast tumors before IVF # Congenital central hypoventilation syndrome
  • In diagnosis of CCHS
  • Prenatal assessment for CCHS in pregnancy
  • To screen for CCHS before IVF
In conjunction with clinical features, histopathological findings; the presence of mutations involving expansion in exon 3 of PHOX2B gene confirms the diagnosis of hereditary neuroblast tumor. In conjunction with clinical features, and presence of polyalanine repeat expansion in PHOX2B gene helps in diagnosis of CCHS.

Negative for mutation analyze (No reportable pathogenic variants were identified)

Polymerase chain reaction, Sequencing, Gene-targeted deletion/duplication analysis, gel electrophoresis.

Whole Blood EDTA (Lavender) or Heparin (Green). Saliva or buccal swab. 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable

 

Stability (saliva)

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: up to 1 month
B-Type Natriuretic Peptide (BNP), Cerebrospinal Fluid Microscopic Evaluation, 1p/19q Deletion in Gliomas, FISH, Tissue, Biopsy, Brain.
1-2 weeks
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login